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The inflammatory response is tightly regulated to control its duration and magnitude and to limit the extent of collateral damage to host tissues. Improper regulation can lead to exaggerated inflammatory responses and pathology. Chronic inflammation is destructive to tissues and is a pathological component of many diverse diseases including cancer, cardiovascular disease, insulin-resistant diabetes as well as neurological diseases.
Ataxia-telangiectasia (AT) is a pleiotropic, recessive genetic disorder that occurs in an estimated one in 40,000 to 100,000 live births. AT affects multiple organ systems and is characterized by progressive neurodegeneration, radiosensitivity, sterility, growth defects, variable immunodeficiency and increased susceptibility to cancer 1 . Until now, immune dysfunction in AT has been characterized by improper B-and T-cell maturation [2] [3] [4] [5] , immunoglobulin deficiencies and impaired antibody responses observed in about two-thirds of patients 6, 7 . Patients often suffer from recurring respiratory tract infections and chronic interstitial inflammatory lung disease, though opportunistic infections are uncommon 8, 9 . Many symptoms in AT patients, including increased incidence of autoimmunity 10 , oxidative stress 11 , cardiovascular disease, insulin resistance, and elevated serum levels of inflammatory cytokines 12, 13 , suggest that they also suffer from pathological inflammation. Furthermore, there are several reports on patients presenting with chronic cutaneous granulomas and pulmonary inflammation without apparent underlying infections [14] [15] [16] [17] . Although the immune defects in the adaptive arm of the immune system associated with this disease have been well studied, the effects on the innate immune system remain poorly understood.
Biallelic mutations in ataxia-telangiectasia mutated (ATM) are the underlying cause of AT. ATM is a large serine/threonine protein kinase involved in various cellular processes 18 . ATM is an important sensor of DNA damage, along with ATR (ataxia telangiectasia and RAD3-related) and DNA-PK (DNA-dependent protein kinase). In response to genotoxic insults, ATM is phosphorylated and then initiates and coordinates DNA-PK are activated in response to double strand breaks, and ATR by single strand breaks and incompletely replicated DNA 19 . Substrates of these kinases include histone variant H2A.X (a marker of DNA damage known as γ-H2A.X when phosphorylated), cell cycle regulators Chk1 and Chk2, as well as the apoptosis regulator p53 18 . The role of ATM in regulating cellular processes is not limited to DNA damage; it also coordinates responses to other forms of stress to restore homeostasis 20 . Notably, ATM was recently shown to be activated by oxidative stress 21 and was suggested to be involved in redox regulation. 22 Neutrophils are the first cells recruited in large numbers to sites of inflammation where, in addition to antimicrobial activity, they exert both pro-and anti-inflammatory functions to balance the immune response 23 . Recognition of microbial components via pattern recognition receptors stimulates neutrophils by activating NF-κB and initiating mitogen-activated protein kinase (MAPK) signaling cascades. These pathways result in the production and secretion of pro-inflammatory cytokines, including interleukin 8 (IL-8) and macrophage inflammatory protein-1α (MIP-1α), which recruit and activate more immune cells. Activated neutrophils additionally mount an oxidative burst, producing large amounts of reactive oxygen species (ROS) via the NADPH oxidase complex. ROS are highly volatile molecules that damage many cellular components of microbes as well as the host, and additionally function as signaling molecules 24 .
Neutrophils contribute to the regulation of inflammation through multiple processes. Their lifespan is tightly regulated to limit their pro-inflammatory functions.
Additionally, apoptosis of the large population of infiltrating neutrophils provides a strong anti-inflammatory signal via efferocytosis, the removal of apoptotic cells via phagocytosis by other immune cells. Efferocytosis dampens pro-inflammatory cytokine production and initiates the resolution of inflammation 25, 26 . In addition to antimicrobial activity, the oxidative burst in phagocytes contributes to regulation of both cytokine production and apoptosis, thus playing an important role in balancing inflammation 27 
Here we show that neutrophils from AT patients overproduce pro-inflammatory cytokines and have a longer lifespan than those from healthy controls. We demonstrate that the activation of ATM and the DNA damage response in neutrophils normally plays a role in regulating cytokine production and apoptosis in a manner dependent on NADPH oxidase activity. Furthermore, we describe a similar effect of ATM inhibition on monocyte cytokine production, suggesting the existence of a common regulatory mechanism in myeloid cells. The absence of ATM activity, as with the oxidative burst, could thus disrupt immune regulation and potentially tip the scales in the direction of chronic inflammation.
Methods

Donor consent
Our study was conducted in accordance with the Helsinki Declaration. Blood samples were collected with approval from the ethical committees of each institution. Informed consent was provided by all patients, or by their parents, in the case of children. At the time of blood donation participants displayed no signs of infection or malignancy.
Patients were receiving no treatments or medications apart from regular intravenous immunoglobulin therapy.
Neutrophil and Monocyte Isolation
Human neutrophils were isolated by centrifuging heparinized venous blood over Histopaque 1119 (Sigma-Aldrich) and subsequently over a discontinuous Percoll (Amersham Biosciences) gradient as previously described 28 . Peripheral blood monocytes were isolated by MACS selection using magnetically-labeled CD14 microbeads (Miltenyi Biotec). Cell preparations were at least 95% neutrophils or monocytes. were cultured in RPMI (Gibco) supplemented with 100 units/ml penicillin and streptomycin, 292 µg/ml L-glutamine (Gibco) and 10% fetal calf serum (Sigma).
Cytokine Production Assays
Cells were seeded in 96-well plates with indicated inhibitors or DMSO control and 
Annexin V Viability Assay
Neutrophil viability was determined using the PE-Annexin V apoptosis kit (BD Biosciences). Briefly, neutrophils were resuspended at the indicated time points, washed in Annexin V binding buffer, stained with PE-Annexin V and vital dye propidium iodide (PI) and then analyzed by flow cytometry. Annexin V/PI double negative neutrophils were defined as viable (Supplemental Figure S3 ). We found that we typically recover more than 90% of the cells after 18 hours. At least 10,000 cells were measured per sample.
Quantitative Real Time PCR
RNA was isolated with RNeasy mini kit (Qiagen). cDNA was made using High-capacity RNA-to-cDNA kit (Applied Biosystems) according to manufacturer's protocol. Quantative 
Results
We assayed the effects of ATM activity on neutrophil functions by incubating cells with various inflammatory stimuli in the presence of KU-55933, a highly specific small molecule inhibitor of ATM 30 . Neutrophils express functional ATM, which is phosphorylated in response to irradiation-induced DNA damage and this activation is abrogated in the presence of KU-55933 ( Figure 1A ). We found that this inhibitor caused a strong dose-dependent increase in the secretion of IL-8 and MIP-1α in response to LPS, a component of bacterial outer membranes ( Figure 1B ). The specificity of this effect was confirmed using a second inhibitor of ATM, KU-60019 (Supplemental Figure   S1 ). We observed an increase in cytokine production in the presence of KU-55933 not only in response to LPS-stimulation, but also in response to opsonized zymosan, flagellin, and heat-killed Listeria monocytogenes ( Figure 1C ). An increase in the production of IL-6 in response to LPS and heat-killed Listeria was similarly observed (Supplemental Figure S2 ). Moreover, ATM inhibition in peripheral blood monocytes significantly increased the production of IL-1β, IL-6, and TNF in response to LPS stimulation ( Figure 1D ).
To determine if genetic deficiencies in ATM affect neutrophil cytokine production in patients, we measured IL-8 production from primary peripheral blood neutrophils isolated from 11 different patients with AT (mean age=16 years). One of these patients participated twice on separate occasions (n=12). All patients were free of infections and malignancy at the time of blood donation. AT diagnoses were confirmed by ATM gene sequencing ( Supplemental Table S1 ). Neutrophils isolated from 12 sex-matched healthy donors were used as controls (mean age=28, n=12). Neutrophils were isolated and experiments performed with one AT patient and one control concurrently. Neutrophils from patients with AT produced significantly more IL-8 (mean = 1.73 ng/10 6 cells) in response to LPS than healthy controls (mean = 0.69 ng/10 6 cells) ( Figure 2A ). These data, complemented by our experiments with ATM inhibitors, show that cytokine production is increased in the absence of ATM activity.
Because neutrophil apoptosis is regulated by p53, which can be induced by ATM activation 31 , we asked whether ATM deficiency affects neutrophil lifespan. Cell viability
was assayed by flow cytometry over an 18-hour time course by staining with PE-labeled annexin V (which binds exposed phosphatidylserine on the surface of apoptotic cells), and propidium iodide (PI, a vital DNA dye), at the indicated time points. We found that neutrophils from AT patients lived significantly longer than controls ( Figure 2B ). We confirmed this result by measuring viability with the Sub-G1 assay (Supplemental Figure   S4 ). Taken together, these data show that primary neutrophils from AT patients overproduce inflammatory cytokines and delay constitutive apoptosis.
In response to LPS stimulation, the MAP kinases ERK and p38 are activated by phosphorylation while IκBα, an inhibitor of the transcription factor NF-κB, is degraded.
To determine if ATM regulates the activation or duration of these signaling pathways, we measured their activation in response to LPS stimulation by western blot. In a 3-hour time course of LPS stimulation we observed phosphorylation of ATM and histone H2A.X.
Phosphorylation of ATM, but not H2A.X, in response to LPS was abrogated by the addition of KU-55933, while p38 phosphorylation was increased ( Figure 3A and B). We similarly observed increased ERK phosphorylation and degradation of IκBα, but only at later timepoints (Supplemental Figure S5) . We then used inhibitors of p38 and ERK to determine if IL-8 overproduction in the absence of ATM activity is dependent on these MAP kinases. P38 inhibition blocked IL-8 production in controls, and abrogated the overpoduction of IL-8 in response to ATM inhibition ( Figure 3C ).
Increased MAPK and NF-κB activation in the absence of ATM activity led to increased cytokine transcription. We observed an increase in both IL-8 and MIP-1α transcripts in the presence of KU-55933 compared to the housekeeping gene β 2microglobulin by qPCR, (Figure 3D ). Correspondingly, we observed an increase in IL-8 protein in neutrophils stimulated in the presence of KU-55933, as shown by intracellular antibody staining and analysis by flow cytometry ( Figure 3E ).
We next used a panel of small molecule inhibitors targeting specific kinases involved in the DNA damage response to determine if other members of this pathway influence cytokine production. Inhibition of ATR, DNA-PK and Chk2 increased IL-8 production in response to LPS, similar to ATM inhibition and consistent with their partially redundant roles in the DNA damage response ( Figure 4A ). In line with this, ATM and ATR inhibition synergistically increases cytokine production above the level of either Figure S5 ). Interestingly, inhibiting p53 drastically prolonged neutrophil life span ( Figure 4B ) but did not affect IL-8 production ( Figure 4A ).
Thus, increased cytokine production in the absence of DNA damage signaling is not strictly linked to prolonged lifespan.
These data suggest that DNA damage signaling downregulates neutrophil cytokine production. To directly test this hypothesis, we pre-incubated neutrophils for one hour with cisplatin or etoposide, two chemical inducers of DNA damage, or exposed them to 10 Gy of γ -irradiation before stimulating them with LPS. These treatments induced DNA damage and activated ATM, as shown by western blot analysis of histone γ-H2A.X and phospho-ATM ( Figure 4C) , and significantly reduced the production of IL-8
( Figure 4D ). Interestingly, treatment with etoposide or irradiation strongly activated ATM and reduced cytokine production without large effects on cell viability after 8 hours ( Figure 4E ). Together, these results show that activation of the DNA damage response suppresses cytokine production and contributes to neutrophil apoptosis.
Since ROS can cause oxidative damage to DNA, we hypothesized that the oxidative burst mounted upon stimulation may activate the DNA damage response in neutrophils. We tested this by using PMA and opsonized zymosan, two potent inducers of the oxidative burst (Supplemental Figure S6) . In response to PMA, we observed an accumulation of phospho-ATM staining in the nuclei of stimulated neutrophils (Supplemental Figure S7 ). We tested the ROS dependence of this activation using pyrocatechol ( Figure 5A ), a cell permeable ROS scavenger capable of neutralizing the oxidative burst as shown in Supplemental Figure S8 . In the presence of pyrocatechol, activated neutrophils showed less phosphorylation of ATM compared to controls ( Figure   5A ). We confirmed the activation of DNA damage signaling by western blot analysis in neutrophils stimulated with PMA and opsonized zymosan ( Figure 5B ). Stimulation To test if the oxidative burst is the endogenous source of ROS activating the DNA damage response, we similarly evaluated ATM activation in neutrophils from patients with chronic granulomatous disease (CGD). CGD is a genetic disorder in which
neutrophils fail to mount an oxidative burst due to deficiencies in NADPH oxidase (Supplemental Figure S9 ). Interestingly, we could show that ATM is effectively activated in neutrophils isolated from CGD patients in response to irradiation, but not in response to ROS-inducing stimuli ( Figure 5C ). This confirms that NADPH oxidase-derived ROS are required for activating the DNA damage response in stimulated neutrophils.
Our results predict that CGD neutrophils, similar to AT neutrophils, would produce more cytokines due to impaired activation of ATM and the DNA damage response. We confirmed this by comparing cytokine production from patients with the two deficiencies: neutrophils isolated concurrently from both a CGD and an AT patient produced more IL-8 than cells from a healthy control ( Figure 5D ). We obtained similar results when incubating neutrophils with ROS scavenger pyrocatechol or ATM inhibitor KU-55933 ( Figure 5E ). This is consistent with published reports on the hyperactivation of CGD phagocytes [32] [33] [34] . Furthermore, we could rescue the IL-8 overproduction phenotype of ROS-scavenged cells by exogenously inducing DNA damage ( Figure 5F ). Etoposide treatment potently decreased IL-8 production from pyrocatechol-treated neutrophils back to levels similar to control cells.
Discussion
Our study is, to the best of our knowledge, the first to examine primary innate immune cells from AT patients. We show that ROS-mediated activation of DNA damage signaling in neutrophils suppresses the production of pro-inflammatory cytokines and activates apoptosis. Accordingly, we report that deficiencies in the DNA damage response, similar to deficiencies in the oxidative burst, result in the overproduction of cytokines and delayed apoptosis. We demonstrate a key role for ATM and show that cytokine production and apoptosis are dysregulated in neutrophils from patients with AT.
These results further our understanding of the ROS-mediated regulation of inflammation and indicate an interesting link between two diverse diseases, AT and CGD. Moreover, our results suggest that innate immune dysfunction may drive inflammation in AT.
The specific mechanisms by which ATM and the DNA damage response contribute to the regulation of cytokine production are not completely clear. The effect is at least partially mediated by modulating well-described MAPK signaling pathways. Our
data demonstrates an important role for p38 and suggests one for ERK as well. It has previously been reported that ATM and other members of the DNA damage response can affect the activation of MAP kinases and NF-κB 35, 36 , which are important regulators of cell survival and inflammation 37 .
Consistent with our findings, several lines of evidence have recently emerged which point to ATM having a major role in suppressing inflammation. In human dendritic cells ATM was shown to be a negative regulator of IL-23 production 38 . Furthermore, pharmacological induction of the DNA damage response reduces levels of proinflammatory cytokines and increases survival in septic mice 39 . This protective effect was shown to be partly mediated by ATM activation, although the researchers conclude that this is a lung specific mechanism not mediated by blood cells. Similarly, Härtlova et al 40 reported that ATM deficiency in macrophages increases production of type I interferon. The authors, however, do not suggest a direct role for ATM in interferon regulation. Rather, they propose that unrepaired DNA lesions in AT cells activate Stimulator of IFN Genes (STING) and prime the type I interferon system. This mechanism and the ROS-mediated one proposed by our study are not mutually exclusive. It would be interesting to examine if other cytokines, including IL-8, are also upregulated in AT macrophages.
Our data indicate that ATM is not the sole member of the DNA damage response that regulates neutrophil function. Inhibition of DNA damage sensors ATR and DNA-PK, as well as Chk2, a substrate of ATM, also increased cytokine production. These sensors are often described as each recognizing a specific type of damage to DNA and executing parallel but discrete responses through different downstream mediators. In reality there is much overlap and crosstalk between these pathways and substrates, meaning they may be partially redundant 41 . Indeed, we observe that simultaneous inhibition of ATM and ATR synergistically increases cytokine production more than either inhibitor alone (Supplemental figure S5 ). Chk2 has been shown to affect MAP kinase activation 42, 43 and can also be activated by ATR, though less efficiently than by ATM 44 .
Thus, these kinases may converge on Chk2 to regulate cytokine production.
Neutrophil cytokine production and lifespan are closely linked and may affect each other. Secretion of IL-8 can increase lifespan by autocrine signaling 45 , and is one possible mechanism causing increased viability in AT cells. We can, however, conclude
that the regulation of cytokine production by the DNA damage response can be uncoupled from its regulation of apoptosis. Inhibiting p53 dramatically prolonged neutrophil lifespan, but did not increase IL-8 production. Futhermore, normalizing cytokine production to viable cells at an earlier timepoint clarifies that when ATM is inhibited, the production of IL-8 increases in magnitude and is not only a result of an increased lifespan (Supplemental Figure 10) . Similarly, inducing DNA damage by treatment with etoposide, or irradiation reduced cytokine production, but had no effect on apoptosis in the time span under investigation.
One of the most prominent neutrophil responses to activating stimuli, in addition to cytokine production, is the oxidative burst. Production of superoxide and its derivatives hydrogen peroxide and hypochlorous acid is thought to contribute to microbial killing, and also serve important signaling functions 23 . ROS are known to induce DNA damage and to activate ATM directly by oxidation 21 
Furthermore, our model suggests a potential mechanistic link between the pathologies observed in two completely different diseases: AT and CGD (Supplemental Figure S11 ). ROS are ubiquitous and promiscuous molecules, playing a role in signaling and regulation of many pathways. In neutrophils, the oxidative burst is known to regulate antimicrobial responses, apoptosis, autophagy, hypoxia and oxidative stress responses, chemotaxis, and NETosis 23 . CGD is the result of dysregulation of all of these responses, which causes immunodeficiency and hyperinflammation. Similarly, AT is the result of dysfunctions in many pathways involving ATM. We propose that the ROS-mediated activation of ATM is an important response which is dysregulated in AT that affects cytokine production; a dysregulation that is shared by patients with CGD. Though these diseases are very different, they may have an inflammatory common denominator.
Chronic inflammation, granuloma formation, and elevated risk of autoimmune disorders in CGD are attributed to increased cytokine production and delayed apoptosis of neutrophils and macrophages 34 . We observe similar dysregulation of neutrophil functions in AT patients and believe this may also drive chronic inflammation and disease in AT. In agreement with this, several authors have reported instances of nonresolving, sterile skin granulomas in AT patients. Furthermore, both AT and CGD patients have an elevated risk of developing autoimmune diseases and autoantibodies [46] [47] [48] [49] . Prolonged inflammatory responses could drive and exacerbate the inflammatory symptoms of AT and even contribute to neurodegeneration and high rates of cancer. Several reports have suggested excessive inflammatory responses in a mouse model of AT, resulting in increased susceptibility to colitis 50 as well as inflammatory tissue damage in the lung 51 .
There is currently no treatment available for AT other than palliative care.
Interestingly, Chessa et al. 52 found that treatment with the anti-inflammatory steroid betamethasone improved neurological symptoms for AT patients, though it remains to be seen if this effect was mediated by the immunosuppressive properties of the drug.
Our work further strengthens the argument that targeting inflammation may be a promising clinical intervention for some of the symptoms of this devastating disease. Asterisks indicate significant increases: *P<0.05, **P<0.01, ***P<0.001 by paired t-test. 
